NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Luna Diabetes

Luna Diabetes

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.lunadiabetes.com/

Last Round

Series A

Aug 18, 2025

Est. Valuation

$45.5M

Total Funding Raised

$23.6M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Luna Diabetes is a medical device company that develops an automated insulin delivery patch pump system designed for nighttime glucose control for insulin pen users.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Medical AI, Clinical Trials

Business Model

B2C

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Application

Keywords

insulin patch pumpautomated insulin deliveryAIDclosed-loop dosingcontinuous glucose monitorCGMartificial pancreasdiabetes managementtime-in-rangeTIRmultiple daily injectionsMDImedical devicedigital healthwearable medical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Luna Diabetes Comps

Public and private peers based on sector, stage, and business model.

Luna Diabetes comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Luna Diabetes Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 18, 2025

Key People

Founding team and executive leadership

John Sjolund

CEO Co-Founder

Founding Team

Luna Diabetes Investors

Notable investors and investment history

Luna Diabetes investors
InvestorRounds
2468 VenturesSeries A
Serpentine VenturesSeries A
Vensana CapitalSeries A
Winklevoss CapitalSeries A
Interlock CapitalSeries A
Credit Suisse Group AGSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 25, 2025

    Developing a new insulin delivery method for insulin pen users.

  • Aug 18, 2025

    $24M round completed.

Luna Diabetes Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Luna Diabetes Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Luna Diabetes's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range17
Year Founded2020
Last FundingAug 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.